Study of immune response to hepatitis B vaccine
Part of Immune system & allergy, Infections clinical trials.
This study looks at how your body's cells respond after getting a hepatitis B vaccine. It may help researchers understand how well the vaccine works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must have had a blood test for hepatitis B within 4 weeks before getting the vaccine.
- You must not be pregnant or breastfeeding.
- You must not have a chronic illness that weakens the immune system, like a missing spleen, blood cancer, autoimmune disease on immune-suppressing drugs, or HIV.
- You must have health insurance (like Social Security or Universal Medical Coverage).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase study tests whether a hepatitis B vaccine (with an added ingredient to boost the immune response) can safely help people with long-term hepatitis B who are already on antiviral therapy. It is mainly looking at safety and how the immune system responds.
This trial tests an experimental vaccine therapy to help control or possibly cure chronic hepatitis B. It is designed to see whether the treatment is safe and how well it affects the hepatitis B virus in adults.
This Phase 3 study tests how well an in-house hepatitis B vaccine works in people’s bodies and whether it’s safe. It may help confirm the vaccine’s effectiveness for people in Indonesia, including children and adults.
This study looks at the genes of people with chronic hepatitis B (HBV) to find why some people's immune cells (B cells and NK cells) stop working properly. The goal is to discover new ways to treat the disease.
This study builds a group of people to measure small hepatitis B “viral RNA” signals in the blood. The goal is to see if these measurements could help researchers find a functional cure and better understand who may respond over time.
This trial studies how your immune system responds after a COVID-19 vaccine. It uses detailed blood tests to understand what changes happen in your immune cells and may help researchers improve future vaccines.
Hear when a new Immune Response trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.